Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC
Clinical trial NCT03858972 · TERMINATED
Trial details
- NCT number
- NCT03858972
- Sponsor
- Odonate Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2021-06-11
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.